Ethel D. Weld

Ethel D. Weld

Infectious Disease | Hospital Medicine
Baltimore, MD 21224

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Curated Cases from the TB Expert Network: Unplugged!: Navigating Uncertainty in Treatment of a Child with Multidrug-Resistant Tuberculosis.

Curated Cases from the TB Expert Network: Unplugged!: Navigating Uncertainty in Treatment of a Child with Multidrug-Resistant Tuberculosis.

Journal: Journal of clinical tuberculosis and other mycobacterial diseases
Published: May 08, 2026

Long-Acting Antiretroviral Therapy to Treat Advanced Human Immunodeficiency Virus in Pregnancy: Let Not Delayed Detection Be the Enemy of the Good.

Long-Acting Antiretroviral Therapy to Treat Advanced Human Immunodeficiency Virus in Pregnancy: Let Not Delayed Detection Be the Enemy of the Good.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 27, 2026

A White Paper on Advancing Long-Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and Regulation.

A White Paper on Advancing Long-Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and Regulation.

Journal: Clinical pharmacology and therapeutics
Published: November 15, 2025

Advancing Maternal Health with Long-Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies.

Advancing Maternal Health with Long-Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies.

Journal: Clinical pharmacology and therapeutics
Published: November 07, 2025

Islatravir distribution in plasma, peripheral blood mononuclear cells, and mucosal tissues after monthly oral dosing.

Islatravir distribution in plasma, peripheral blood mononuclear cells, and mucosal tissues after monthly oral dosing.

Journal: AIDS (London, England)
Published: November 03, 2025

5' leader defects drive persistent HIV-1 viremia on long-term ART.

5' leader defects drive persistent HIV-1 viremia on long-term ART.

Journal: Nature communications
Published: October 21, 2025

Exploring Preferences, Concerns, and Implementation of Different Long-Acting Antiretroviral Strategies for Youth with HIV Facing Adherence Challenges.

Exploring Preferences, Concerns, and Implementation of Different Long-Acting Antiretroviral Strategies for Youth with HIV Facing Adherence Challenges.

Journal: AIDS patient care and STDs
Published: June 05, 2025

Investigations of Long-Acting Formulations in Children, Adolescents, and Pregnant Women: A Systematic Review.

Investigations of Long-Acting Formulations in Children, Adolescents, and Pregnant Women: A Systematic Review.

Journal: Pharmaceutics
Published: October 04, 2024

Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial.

Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial.

Journal: The lancet. HIV
Published: September 09, 2024

Strategic use of salvage long-acting antiretrovirals in the setting of resistance.

Strategic use of salvage long-acting antiretrovirals in the setting of resistance.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: July 24, 2024

Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C Virus: A Survey of Patients in Diverse Low- and Middle-Income Countries.

Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C Virus: A Survey of Patients in Diverse Low- and Middle-Income Countries.

Journal: Journal of viral hepatitis
Published: July 23, 2024

Acceptability of a rectal microbicide douche for HIV prevention: a mixed-methods analysis of a first-in-human formulation pilot study.

Acceptability of a rectal microbicide douche for HIV prevention: a mixed-methods analysis of a first-in-human formulation pilot study.

Journal: Sexually transmitted infections
Published: April 15, 2024
Showing 1-12 of 41

Last Updated: 09/26/2026